Table 3 Obesity indices and other cardiometabolic risk factors across month 0 and month 6 of study subjects in both arms (control and low glycemic index, GI, groups)

Obesity indices

Body weight (kg)

82.9 (14.9)

87.6 (13.0)

83.0 (13.1)

84.3 (14.4)

Body mass index (kg/m²)

30.2 (3.5)

31.6 (4.2)

30.0 (2.9)

30.4 (4.0)

Waist circumference (cm)

92.3 (9.8)

96.5 (10.9)

90.5 (10.2)

91.2 (10.5)

Body fat (%)

36.8 (8.3)

39.8 (7.3)

35.9 (7.4)

38.5 (8.9)

Trunk fat (%)

40.5 (7.2)

42.9 (6.1)

39.0 (7.1)

41.6 (6.9)

Visceral fat (%)^†

12.5 (9.0 – 19.0)

14.2 (10.8 – 19.8)

13.5 (7.5 – 20.5)

12.0 (10.0 – 19.0)

Other cardiometabolic risk factors

Systolic blood pressure (mmHg)

121.6 (10.2)

123.1 (9.7)

120.7 (10.6)

123.0 (10.0)

Diastolic blood pressure (mmHg)

72.4 (8.7)

74.0 (8.0)

72.4 (9.8)

74.3 (7.0)

Total cholesterol (mmol/L)

4.4 (0.7)

4.2 (0.7)

4.2 (0.8)

4.0 (0.8)

HDL-cholesterol (mmol/L)

1.3 (0.3)

1.2 (0.3)

1.2 (0.3)

1.2 (0.2)

LDL-cholesterol (mmol/L)

2.6 (0.7)

2.5 (0.6)

2.4 (0.7)

2.3 (0.7)

Non HDL-cholesterol (mmol/L)

3.1 (0.7)

3.0 (0.7)

3.0 (0.7)

2.8 (0.8)

Triglyceride (mmol/L)

1.1 (0.4)

1.0 (0.4)

1.3 (0.5)

1.1 (0.5)

Urine ACR (mg/mmol)^†

0.45 (0.26 – 0.84)

0.56 (0.33 – 1.32)

0.79 (0.32 – 1.44)

0.55 (0.30 – 0.99)

Fasting plasma glucose (mmol/L)

4.6 (0.3)

4.7 (0.3)

4.7 (0.5)

4.7 (0.4)

Two-hour FPG (mmol/L)

6.0 (1.3)

6.1 (1.2)

6.0 (1.5)

6.0 (2.0)

AUC glucose (10² mmol/L * min)

8.1 (1.3)

8.5 (1.3)

8.4 (1.6)

8.6 (2.1)